| Title |
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.
|
|---|---|
| Published in |
Journal of Rheumatology, December 1988
|
| Pubmed ID | |
| Authors |
N Bellamy, W W Buchanan, C H Goldsmith, J Campbell, L W Stitt |
| Abstract |
Within the context of a double blind randomized controlled parallel trial of 2 nonsteroidal antiinflammatory drugs, we validated WOMAC, a new multidimensional, self-administered health status instrument for patients with osteoarthritis of the hip or knee. The pain, stiffness and physical function subscales fulfil conventional criteria for face, content and construct validity, reliability, responsiveness and relative efficiency. WOMAC is a disease-specific purpose built high performance instrument for evaluative research in osteoarthritis clinical trials. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,359 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | <1% |
| Spain | 5 | <1% |
| United Kingdom | 4 | <1% |
| Italy | 3 | <1% |
| Brazil | 2 | <1% |
| Germany | 2 | <1% |
| Finland | 1 | <1% |
| Canada | 1 | <1% |
| Austria | 1 | <1% |
| Other | 4 | <1% |
| Unknown | 1330 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 170 | 13% |
| Student > Ph. D. Student | 164 | 12% |
| Student > Master | 161 | 12% |
| Student > Bachelor | 110 | 8% |
| Other | 100 | 7% |
| Other | 327 | 24% |
| Unknown | 327 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 456 | 34% |
| Nursing and Health Professions | 105 | 8% |
| Engineering | 65 | 5% |
| Agricultural and Biological Sciences | 52 | 4% |
| Sports and Recreations | 40 | 3% |
| Other | 202 | 15% |
| Unknown | 439 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 August 2023.
All research outputs
#3,394,129
of 25,382,440 outputs
Outputs from Journal of Rheumatology
#620
of 3,951 outputs
Outputs of similar age
#1,762
of 53,900 outputs
Outputs of similar age from Journal of Rheumatology
#1
of 3 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,951 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 53,900 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them